Otsuka Pharmaceutical proudly announces that its subsidiaries in Indonesia, PT Otsuka Indonesia (PTOI) and PT Amerta Indah Otsuka (PTAIO), have been honored with the prestigious 2024 Ending Workplace Tuberculosis (EWTB) Exemplar Award. This esteemed recognition, coinciding with World TB Day…
Pfizer Inc. (NYSE: PFE) has disclosed promising findings from a Phase 3 clinical trial investigating the efficacy of the antibody-drug conjugate ADCETRIS® (brentuximab vedotin) in conjunction with lenalidomide and rituximab for treating patients afflicted with relapsed/refractory diffuse large B-cell lymphoma…
A recent comprehensive study, published in The Lancet Neurology, has revealed staggering figures regarding neurological conditions worldwide. In 2021, over 3 billion individuals were found to be living with such conditions, marking them as the foremost cause of global illness…
The Role of Quality Control at Orion Pharmaceuticals Maija Blomquist, the Quality Control Manager for Materials, Gels & Ointments, underscores the pivotal role of quality control in maintaining Orion’s product standards. Acting as sentinels throughout the production cycle, her team…
Novo Nordisk has announced today that the US Food and Drug Administration (FDA) has granted approval for an expanded label for Wegovy®. This approval, based on a supplemental New Drug Application (sNDA), extends the indication of Wegovy® to include the…
Oragenics, Inc. (NYSE American: OGEN), a company dedicated to developing innovative intranasal pharmaceuticals for neurological disorders, has revealed its readiness to embark on the final stages of GMP manufacturing and formulation for its drug candidate, ahead of the anticipated Phase…
PQE Group eagerly anticipates participating in the 2024 PDA India Chapter Annual Meeting in Hyderabad from March 11-15, focusing on critical issues in the pharmaceutical and medical device sectors. The conference will delve into topics such as environmental monitoring, aseptic…
Vivani Medical, Inc. (Nasdaq: VANI), a pioneering biopharmaceutical company in the preclinical stage, has recently announced a significant move towards advancing its innovative long-term drug implants. In a registered direct offering, the company has entered into a securities purchase agreement…
President and CEO of Bio-Techne, Kim Kelderman, commented on the results, acknowledging the team’s resilience in a challenging environment. He expressed optimism regarding the stabilization observed in China and reiterated confidence in the company’s long-term growth prospects. Kelderman also expressed…
Roche (SIX: RO, ROG; OTCQX: RHHBY) has revealed the findings from Stage 1 of the National Institutes of Health (NIH)-sponsored pivotal Phase III OUtMATCH study, assessing the effectiveness and safety of Xolair® (omalizumab) in patients with peanut allergies and allergies…
Celltrion presented encouraging findings from the extensive LIBERTY studies, including LIBERTY-CD 1 and LIBERTY-UC 2, focusing on patients with Alzheimer’s disease, Crohn’s disease (CD), or moderately to severely active ulcerative colitis (UC). Additionally, the company shared endoscopic results from a…
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a company specializing in gastrointestinal healthcare, has revealed plans to present findings from four studies examining apraglutide in adults diagnosed with short bowel syndrome with intestinal failure (SBS-IF), a condition where individuals rely on parenteral…
